oritavancin

Term ID

CHEBI:82699

Synonyms

(4''R)-22-O-(3-amino-2,3,6-trideoxy-3-C-methyl-alpha-L-arabino-hexopyranosyl)-N(3'')-((4'-chloro(1,1'-biphenyl)-4-yl)methyl)vancomycin
(4''R)-22-O-(3-Amino-2,3,6-trideoxy-3-C-methyl-alpha-L-arabinohexopyranosyl)-N3''-(p-(p-chlorophenyl)benzyl)vancomycin
Chlorobiphenyl-chloroeremomycin
LY333328

Definition

A semisynthetic glycopeptide used (as its bisphosphate salt) for the treatment of acute bacterial skin and skin structure infections caused or suspected to be caused by susceptible isolates of designated Gram-positive microorganisms including MRSA.

References

Ontology

ChEBI ( EBI )

Relationships

is a type of: disaccharide derivative glycopeptide semisynthetic derivative

disaccharide derivative glycopeptide semisynthetic derivative Show first 5 Terms
has_functional_parent: vancomycin aglycone

vancomycin aglycone Show first 5 Terms
has_role: antibacterial drug antimicrobial agent

antibacterial drug antimicrobial agent Show first 5 Terms
inverse has_part: oritavancin bisphosphate

oritavancin bisphosphate Show first 5 Terms

Phenotype

Phenotype resulting from oritavancin

Phenotype where environments contain oritavancin

Phenotype modified by environments containing oritavancin

Human Disease / Model Data

Citations